Form D — Cerium Pharmaceuticals, Inc.
0001677995-26-000003 · filed Aug 6, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,544,000
- Reported amount sold
- $750,000
- Minimum investment
- $0
- Investors
- 4
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Cerium Pharmaceuticals, Inc.
- CIK
- 1677995
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 312 MAIN STREET
GAITHERSBURG, Maryland 20878 - Phone
- 703-229-2508
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gregg A. Lapointe · Executive OfficerGaithersburg, Maryland Find on LinkedIn ↗
-
Peter Collum · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Steve Eskenazi · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Robert Rubin · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Tom DePasquale · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
James Gale · DirectorGaithersburg, Maryland Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗